nodes	percent_of_prediction	percent_of_DWPC	metapath
Ezetimibe—ABCG2—Riluzole—amyotrophic lateral sclerosis	0.666	1	CbGbCtD
Ezetimibe—Cholecystitis—Riluzole—amyotrophic lateral sclerosis	0.00743	0.0404	CcSEcCtD
Ezetimibe—Blood creatine phosphokinase increased—Riluzole—amyotrophic lateral sclerosis	0.0062	0.0337	CcSEcCtD
Ezetimibe—Interstitial lung disease—Riluzole—amyotrophic lateral sclerosis	0.00602	0.0328	CcSEcCtD
Ezetimibe—Gamma-glutamyltransferase increased—Riluzole—amyotrophic lateral sclerosis	0.00518	0.0282	CcSEcCtD
Ezetimibe—Bone disorder—Riluzole—amyotrophic lateral sclerosis	0.00472	0.0257	CcSEcCtD
Ezetimibe—Neck pain—Riluzole—amyotrophic lateral sclerosis	0.00432	0.0235	CcSEcCtD
Ezetimibe—Phosphatase alkaline increased—Riluzole—amyotrophic lateral sclerosis	0.00426	0.0232	CcSEcCtD
Ezetimibe—Hepatocellular injury—Riluzole—amyotrophic lateral sclerosis	0.00426	0.0232	CcSEcCtD
Ezetimibe—Blood alkaline phosphatase increased—Riluzole—amyotrophic lateral sclerosis	0.00356	0.0194	CcSEcCtD
Ezetimibe—Photosensitivity—Riluzole—amyotrophic lateral sclerosis	0.00353	0.0192	CcSEcCtD
Ezetimibe—Amnesia—Riluzole—amyotrophic lateral sclerosis	0.00329	0.0179	CcSEcCtD
Ezetimibe—Arthritis—Riluzole—amyotrophic lateral sclerosis	0.00319	0.0173	CcSEcCtD
Ezetimibe—Liver function test abnormal—Riluzole—amyotrophic lateral sclerosis	0.00286	0.0155	CcSEcCtD
Ezetimibe—Breast disorder—Riluzole—amyotrophic lateral sclerosis	0.0028	0.0152	CcSEcCtD
Ezetimibe—Aspartate aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.00279	0.0152	CcSEcCtD
Ezetimibe—Gastritis—Riluzole—amyotrophic lateral sclerosis	0.00274	0.0149	CcSEcCtD
Ezetimibe—Alanine aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.00273	0.0148	CcSEcCtD
Ezetimibe—Muscular weakness—Riluzole—amyotrophic lateral sclerosis	0.00273	0.0148	CcSEcCtD
Ezetimibe—Influenza—Riluzole—amyotrophic lateral sclerosis	0.00268	0.0145	CcSEcCtD
Ezetimibe—Pancreatitis—Riluzole—amyotrophic lateral sclerosis	0.00262	0.0143	CcSEcCtD
Ezetimibe—Erectile dysfunction—Riluzole—amyotrophic lateral sclerosis	0.00246	0.0134	CcSEcCtD
Ezetimibe—Photosensitivity reaction—Riluzole—amyotrophic lateral sclerosis	0.00244	0.0133	CcSEcCtD
Ezetimibe—Infestation NOS—Riluzole—amyotrophic lateral sclerosis	0.00239	0.013	CcSEcCtD
Ezetimibe—Infestation—Riluzole—amyotrophic lateral sclerosis	0.00239	0.013	CcSEcCtD
Ezetimibe—Neuropathy peripheral—Riluzole—amyotrophic lateral sclerosis	0.00234	0.0127	CcSEcCtD
Ezetimibe—Jaundice—Riluzole—amyotrophic lateral sclerosis	0.00233	0.0126	CcSEcCtD
Ezetimibe—Hepatobiliary disease—Riluzole—amyotrophic lateral sclerosis	0.00226	0.0123	CcSEcCtD
Ezetimibe—Sinusitis—Riluzole—amyotrophic lateral sclerosis	0.00224	0.0122	CcSEcCtD
Ezetimibe—Hepatitis—Riluzole—amyotrophic lateral sclerosis	0.00214	0.0116	CcSEcCtD
Ezetimibe—Pharyngitis—Riluzole—amyotrophic lateral sclerosis	0.00213	0.0116	CcSEcCtD
Ezetimibe—Oedema peripheral—Riluzole—amyotrophic lateral sclerosis	0.00211	0.0115	CcSEcCtD
Ezetimibe—Connective tissue disorder—Riluzole—amyotrophic lateral sclerosis	0.0021	0.0114	CcSEcCtD
Ezetimibe—Erythema multiforme—Riluzole—amyotrophic lateral sclerosis	0.00202	0.011	CcSEcCtD
Ezetimibe—Angiopathy—Riluzole—amyotrophic lateral sclerosis	0.00194	0.0106	CcSEcCtD
Ezetimibe—Immune system disorder—Riluzole—amyotrophic lateral sclerosis	0.00193	0.0105	CcSEcCtD
Ezetimibe—Mediastinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00193	0.0105	CcSEcCtD
Ezetimibe—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.00189	0.0103	CcSEcCtD
Ezetimibe—Mental disorder—Riluzole—amyotrophic lateral sclerosis	0.00188	0.0102	CcSEcCtD
Ezetimibe—Malnutrition—Riluzole—amyotrophic lateral sclerosis	0.00186	0.0101	CcSEcCtD
Ezetimibe—Flatulence—Riluzole—amyotrophic lateral sclerosis	0.00184	0.00999	CcSEcCtD
Ezetimibe—Back pain—Riluzole—amyotrophic lateral sclerosis	0.0018	0.0098	CcSEcCtD
Ezetimibe—Muscle spasms—Riluzole—amyotrophic lateral sclerosis	0.00179	0.00975	CcSEcCtD
Ezetimibe—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.00173	0.0094	CcSEcCtD
Ezetimibe—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.00172	0.00937	CcSEcCtD
Ezetimibe—Angioedema—Riluzole—amyotrophic lateral sclerosis	0.0017	0.00926	CcSEcCtD
Ezetimibe—Malaise—Riluzole—amyotrophic lateral sclerosis	0.00168	0.00914	CcSEcCtD
Ezetimibe—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.00165	0.00896	CcSEcCtD
Ezetimibe—Cough—Riluzole—amyotrophic lateral sclerosis	0.00163	0.00884	CcSEcCtD
Ezetimibe—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.00161	0.00875	CcSEcCtD
Ezetimibe—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.00159	0.00863	CcSEcCtD
Ezetimibe—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.00159	0.00863	CcSEcCtD
Ezetimibe—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.00159	0.00863	CcSEcCtD
Ezetimibe—Unspecified disorder of skin and subcutaneous tissue—Riluzole—amyotrophic lateral sclerosis	0.00158	0.00857	CcSEcCtD
Ezetimibe—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.00157	0.00853	CcSEcCtD
Ezetimibe—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.00155	0.00844	CcSEcCtD
Ezetimibe—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.00153	0.00834	CcSEcCtD
Ezetimibe—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.00152	0.00827	CcSEcCtD
Ezetimibe—Infection—Riluzole—amyotrophic lateral sclerosis	0.00151	0.00822	CcSEcCtD
Ezetimibe—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.00149	0.00811	CcSEcCtD
Ezetimibe—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.00149	0.0081	CcSEcCtD
Ezetimibe—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.00148	0.00804	CcSEcCtD
Ezetimibe—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00139	0.00754	CcSEcCtD
Ezetimibe—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.00138	0.00748	CcSEcCtD
Ezetimibe—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.00137	0.00743	CcSEcCtD
Ezetimibe—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.00136	0.00738	CcSEcCtD
Ezetimibe—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.00134	0.00728	CcSEcCtD
Ezetimibe—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.00132	0.00719	CcSEcCtD
Ezetimibe—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00131	0.00714	CcSEcCtD
Ezetimibe—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.00131	0.00713	CcSEcCtD
Ezetimibe—Constipation—Riluzole—amyotrophic lateral sclerosis	0.0013	0.00707	CcSEcCtD
Ezetimibe—Pain—Riluzole—amyotrophic lateral sclerosis	0.0013	0.00707	CcSEcCtD
Ezetimibe—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.00125	0.00682	CcSEcCtD
Ezetimibe—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.00124	0.00676	CcSEcCtD
Ezetimibe—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.00121	0.00657	CcSEcCtD
Ezetimibe—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.0012	0.00654	CcSEcCtD
Ezetimibe—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.0012	0.00654	CcSEcCtD
Ezetimibe—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.00112	0.00609	CcSEcCtD
Ezetimibe—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00109	0.00594	CcSEcCtD
Ezetimibe—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.00108	0.00585	CcSEcCtD
Ezetimibe—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.00104	0.00566	CcSEcCtD
Ezetimibe—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00101	0.00547	CcSEcCtD
Ezetimibe—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.000967	0.00526	CcSEcCtD
Ezetimibe—Rash—Riluzole—amyotrophic lateral sclerosis	0.000959	0.00522	CcSEcCtD
Ezetimibe—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.000958	0.00521	CcSEcCtD
Ezetimibe—Headache—Riluzole—amyotrophic lateral sclerosis	0.000953	0.00518	CcSEcCtD
Ezetimibe—Nausea—Riluzole—amyotrophic lateral sclerosis	0.000904	0.00491	CcSEcCtD
Ezetimibe—ABCG8—Metabolism—DAO—amyotrophic lateral sclerosis	0.000485	0.00323	CbGpPWpGaD
Ezetimibe—NPC1L1—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000485	0.00323	CbGpPWpGaD
Ezetimibe—UGT1A1—NRF2 pathway—GSR—amyotrophic lateral sclerosis	0.000471	0.00314	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism—DAO—amyotrophic lateral sclerosis	0.000467	0.00311	CbGpPWpGaD
Ezetimibe—ABCC2—NRF2 pathway—GSR—amyotrophic lateral sclerosis	0.00046	0.00306	CbGpPWpGaD
Ezetimibe—UGT1A3—Phase II conjugation—GSTP1—amyotrophic lateral sclerosis	0.000451	0.00301	CbGpPWpGaD
Ezetimibe—NPC1L1—Metabolism—GSR—amyotrophic lateral sclerosis	0.000448	0.00298	CbGpPWpGaD
Ezetimibe—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	0.000444	0.00296	CbGpPWpGaD
Ezetimibe—UGT2B7—NRF2 pathway—SLC6A1—amyotrophic lateral sclerosis	0.000425	0.00283	CbGpPWpGaD
Ezetimibe—ABCC3—NRF2 pathway—SLC6A1—amyotrophic lateral sclerosis	0.000425	0.00283	CbGpPWpGaD
Ezetimibe—UGT1A1—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000408	0.00272	CbGpPWpGaD
Ezetimibe—NPC1L1—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	0.000408	0.00272	CbGpPWpGaD
Ezetimibe—ANPEP—Metabolism of proteins—IGFBP3—amyotrophic lateral sclerosis	0.000399	0.00266	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000386	0.00257	CbGpPWpGaD
Ezetimibe—UGT1A3—NRF2 pathway—SQSTM1—amyotrophic lateral sclerosis	0.000385	0.00256	CbGpPWpGaD
Ezetimibe—UGT2B7—Phase II conjugation—GSTP1—amyotrophic lateral sclerosis	0.000384	0.00256	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000378	0.00252	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000378	0.00252	CbGpPWpGaD
Ezetimibe—NPC1L1—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000367	0.00245	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000367	0.00245	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000354	0.00236	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000353	0.00235	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000346	0.0023	CbGpPWpGaD
Ezetimibe—UGT1A1—NRF2 pathway—SLC6A1—amyotrophic lateral sclerosis	0.000345	0.0023	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism—GSR—amyotrophic lateral sclerosis	0.000339	0.00226	CbGpPWpGaD
Ezetimibe—ABCC2—NRF2 pathway—SLC6A1—amyotrophic lateral sclerosis	0.000337	0.00224	CbGpPWpGaD
Ezetimibe—NPC1L1—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	0.000335	0.00223	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000329	0.00219	CbGpPWpGaD
Ezetimibe—ABCC3—NRF2 pathway—SQSTM1—amyotrophic lateral sclerosis	0.000327	0.00218	CbGpPWpGaD
Ezetimibe—UGT2B7—NRF2 pathway—SQSTM1—amyotrophic lateral sclerosis	0.000327	0.00218	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism—GSR—amyotrophic lateral sclerosis	0.000326	0.00218	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000321	0.00214	CbGpPWpGaD
Ezetimibe—UGT1A1—Phase II conjugation—GSTP1—amyotrophic lateral sclerosis	0.000312	0.00208	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	0.000309	0.00206	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000309	0.00206	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000302	0.00201	CbGpPWpGaD
Ezetimibe—UGT1A3—NRF2 pathway—GSTP1—amyotrophic lateral sclerosis	0.000301	0.00201	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	0.000297	0.00198	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000288	0.00192	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000279	0.00186	CbGpPWpGaD
Ezetimibe—ABCC3—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000278	0.00185	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—DAO—amyotrophic lateral sclerosis	0.000273	0.00182	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000268	0.00179	CbGpPWpGaD
Ezetimibe—UGT1A1—NRF2 pathway—SQSTM1—amyotrophic lateral sclerosis	0.000266	0.00177	CbGpPWpGaD
Ezetimibe—UGT1A3—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000264	0.00176	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000263	0.00175	CbGpPWpGaD
Ezetimibe—SLCO1B1—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	0.000263	0.00175	CbGpPWpGaD
Ezetimibe—UGT1A3—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.00026	0.00174	CbGpPWpGaD
Ezetimibe—ABCC2—NRF2 pathway—SQSTM1—amyotrophic lateral sclerosis	0.000259	0.00173	CbGpPWpGaD
Ezetimibe—ABCC3—Fluoropyrimidine Activity—TP53—amyotrophic lateral sclerosis	0.000259	0.00173	CbGpPWpGaD
Ezetimibe—ABCC3—NRF2 pathway—GSTP1—amyotrophic lateral sclerosis	0.000256	0.00171	CbGpPWpGaD
Ezetimibe—UGT2B7—NRF2 pathway—GSTP1—amyotrophic lateral sclerosis	0.000256	0.00171	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	0.000254	0.00169	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000245	0.00163	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	0.000245	0.00163	CbGpPWpGaD
Ezetimibe—ABCG2—HIF-2-alpha transcription factor network—VEGFA—amyotrophic lateral sclerosis	0.000231	0.00154	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.00023	0.00153	CbGpPWpGaD
Ezetimibe—NPC1L1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	0.00023	0.00153	CbGpPWpGaD
Ezetimibe—UGT2B7—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000225	0.0015	CbGpPWpGaD
Ezetimibe—SLCO1B1—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	0.000224	0.00149	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—CASP12—amyotrophic lateral sclerosis	0.000222	0.00148	CbGpPWpGaD
Ezetimibe—UGT2B7—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000221	0.00148	CbGpPWpGaD
Ezetimibe—ABCC2—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000221	0.00147	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000212	0.00141	CbGpPWpGaD
Ezetimibe—UGT1A1—NRF2 pathway—GSTP1—amyotrophic lateral sclerosis	0.000208	0.00139	CbGpPWpGaD
Ezetimibe—SLCO1B1—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000207	0.00138	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000207	0.00138	CbGpPWpGaD
Ezetimibe—ABCC2—NRF2 pathway—GSTP1—amyotrophic lateral sclerosis	0.000203	0.00135	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000202	0.00135	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000202	0.00135	CbGpPWpGaD
Ezetimibe—SLCO1B1—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	0.000199	0.00133	CbGpPWpGaD
Ezetimibe—NPC1L1—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000198	0.00132	CbGpPWpGaD
Ezetimibe—ABCG2—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000192	0.00128	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—GSR—amyotrophic lateral sclerosis	0.000191	0.00127	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000185	0.00123	CbGpPWpGaD
Ezetimibe—UGT1A1—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000182	0.00122	CbGpPWpGaD
Ezetimibe—NPC1L1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000182	0.00121	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—RARA—amyotrophic lateral sclerosis	0.000181	0.00121	CbGpPWpGaD
Ezetimibe—UGT1A1—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.00018	0.0012	CbGpPWpGaD
Ezetimibe—ABCC3—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000179	0.0012	CbGpPWpGaD
Ezetimibe—ABCG2—Fluoropyrimidine Activity—TP53—amyotrophic lateral sclerosis	0.000179	0.00119	CbGpPWpGaD
Ezetimibe—ABCB1—Allograft Rejection—CASP9—amyotrophic lateral sclerosis	0.000178	0.00119	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	0.000174	0.00116	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000172	0.00115	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000172	0.00115	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000172	0.00115	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000172	0.00115	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000172	0.00115	CbGpPWpGaD
Ezetimibe—ANPEP—Metabolism of proteins—IGF1—amyotrophic lateral sclerosis	0.000169	0.00112	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	0.000168	0.00112	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000162	0.00108	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.00016	0.00107	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000158	0.00105	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000157	0.00105	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000157	0.00105	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000157	0.00105	CbGpPWpGaD
Ezetimibe—ABCC3—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000153	0.00102	CbGpPWpGaD
Ezetimibe—ABCC3—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000153	0.00102	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.00015	0.000997	CbGpPWpGaD
Ezetimibe—NPC1L1—Metabolism—APOE—amyotrophic lateral sclerosis	0.000149	0.000995	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—DAO—amyotrophic lateral sclerosis	0.000146	0.000975	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000146	0.000975	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000146	0.000975	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000144	0.00096	CbGpPWpGaD
Ezetimibe—ABCB1—Allograft Rejection—CD40LG—amyotrophic lateral sclerosis	0.000143	0.000955	CbGpPWpGaD
Ezetimibe—ABCC2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000142	0.000948	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—VAPB—amyotrophic lateral sclerosis	0.00014	0.000932	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—TPK1—amyotrophic lateral sclerosis	0.00014	0.000932	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000138	0.000916	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000138	0.000916	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000138	0.000916	CbGpPWpGaD
Ezetimibe—ABCC3—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000136	0.000906	CbGpPWpGaD
Ezetimibe—ABCG2—HIF-1-alpha transcription factor network—VEGFA—amyotrophic lateral sclerosis	0.000136	0.000906	CbGpPWpGaD
Ezetimibe—SLCO1B1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000134	0.00089	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000132	0.000882	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000128	0.000854	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000128	0.000854	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000128	0.000852	CbGpPWpGaD
Ezetimibe—ABCB1—Allograft Rejection—C3—amyotrophic lateral sclerosis	0.000127	0.000844	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—MAPT—amyotrophic lateral sclerosis	0.000125	0.00083	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—DAO—amyotrophic lateral sclerosis	0.000124	0.000829	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—DAO—amyotrophic lateral sclerosis	0.000124	0.000829	CbGpPWpGaD
Ezetimibe—ABCG2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000124	0.000824	CbGpPWpGaD
Ezetimibe—ABCC2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000121	0.000806	CbGpPWpGaD
Ezetimibe—ABCC2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000121	0.000806	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—CST3—amyotrophic lateral sclerosis	0.000121	0.000805	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.000119	0.000796	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000119	0.000792	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000119	0.00079	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000119	0.00079	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000117	0.000781	CbGpPWpGaD
Ezetimibe—CYP3A4—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000115	0.000768	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—IGFBP3—amyotrophic lateral sclerosis	0.000114	0.000758	CbGpPWpGaD
Ezetimibe—SLCO1B1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000114	0.000757	CbGpPWpGaD
Ezetimibe—SLCO1B1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000114	0.000757	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism—APOE—amyotrophic lateral sclerosis	0.000113	0.000754	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000112	0.000745	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000111	0.000739	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000109	0.000726	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism—APOE—amyotrophic lateral sclerosis	0.000109	0.000726	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000109	0.000723	CbGpPWpGaD
Ezetimibe—ABCC2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000108	0.000718	CbGpPWpGaD
Ezetimibe—ABCG2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000105	0.000701	CbGpPWpGaD
Ezetimibe—ABCG2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000105	0.000701	CbGpPWpGaD
Ezetimibe—ABCB1—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000104	0.000691	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000102	0.000682	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—GSR—amyotrophic lateral sclerosis	0.000102	0.000682	CbGpPWpGaD
Ezetimibe—NPC1L1—Metabolism—PTGS2—amyotrophic lateral sclerosis	0.000102	0.000682	CbGpPWpGaD
Ezetimibe—SLCO1B1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000101	0.000675	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—DAO—amyotrophic lateral sclerosis	0.000101	0.000674	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000101	0.000672	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—FIG4—amyotrophic lateral sclerosis	9.48e-05	0.000632	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—PLB1—amyotrophic lateral sclerosis	9.43e-05	0.000628	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—PLB1—amyotrophic lateral sclerosis	9.43e-05	0.000628	CbGpPWpGaD
Ezetimibe—ABCG2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	9.37e-05	0.000625	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—DAO—amyotrophic lateral sclerosis	9.26e-05	0.000617	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—CASP9—amyotrophic lateral sclerosis	8.79e-05	0.000586	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—GSR—amyotrophic lateral sclerosis	8.7e-05	0.00058	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—GSR—amyotrophic lateral sclerosis	8.7e-05	0.00058	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—DAO—amyotrophic lateral sclerosis	8.58e-05	0.000571	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—GSTP1—amyotrophic lateral sclerosis	8.43e-05	0.000562	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—CHAT—amyotrophic lateral sclerosis	8.4e-05	0.00056	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	7.92e-05	0.000528	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism—PTGS2—amyotrophic lateral sclerosis	7.75e-05	0.000517	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	7.75e-05	0.000516	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—PLB1—amyotrophic lateral sclerosis	7.66e-05	0.00051	CbGpPWpGaD
Ezetimibe—ABCB1—Allograft Rejection—CASP3—amyotrophic lateral sclerosis	7.5e-05	0.0005	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism—PTGS2—amyotrophic lateral sclerosis	7.46e-05	0.000497	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—amyotrophic lateral sclerosis	7.41e-05	0.000494	CbGpPWpGaD
Ezetimibe—ABCB1—HIF-1-alpha transcription factor network—VEGFA—amyotrophic lateral sclerosis	7.35e-05	0.00049	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—CHAT—amyotrophic lateral sclerosis	7.14e-05	0.000476	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—CHAT—amyotrophic lateral sclerosis	7.14e-05	0.000476	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	7.07e-05	0.000471	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—GSR—amyotrophic lateral sclerosis	7.07e-05	0.000471	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—PLB1—amyotrophic lateral sclerosis	7.02e-05	0.000468	CbGpPWpGaD
Ezetimibe—ABCB1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	6.69e-05	0.000446	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	6.52e-05	0.000434	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—PLB1—amyotrophic lateral sclerosis	6.5e-05	0.000433	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—GSR—amyotrophic lateral sclerosis	6.48e-05	0.000432	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—VAPB—amyotrophic lateral sclerosis	6.41e-05	0.000427	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—TPK1—amyotrophic lateral sclerosis	6.41e-05	0.000427	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—APOE—amyotrophic lateral sclerosis	6.37e-05	0.000425	CbGpPWpGaD
Ezetimibe—ABCB1—Allograft Rejection—VEGFA—amyotrophic lateral sclerosis	6.37e-05	0.000424	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—GSR—amyotrophic lateral sclerosis	6e-05	0.0004	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	5.9e-05	0.000393	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—VAPA—amyotrophic lateral sclerosis	5.87e-05	0.000391	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—CHAT—amyotrophic lateral sclerosis	5.81e-05	0.000387	CbGpPWpGaD
Ezetimibe—ABCB1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	5.69e-05	0.000379	CbGpPWpGaD
Ezetimibe—ABCB1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	5.69e-05	0.000379	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—SACM1L—amyotrophic lateral sclerosis	5.45e-05	0.000363	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—CHAT—amyotrophic lateral sclerosis	5.32e-05	0.000354	CbGpPWpGaD
Ezetimibe—CYP3A4—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	5.16e-05	0.000344	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—FIG4—amyotrophic lateral sclerosis	5.13e-05	0.000342	CbGpPWpGaD
Ezetimibe—CYP3A4—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	5.09e-05	0.000339	CbGpPWpGaD
Ezetimibe—ABCB1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	5.07e-05	0.000338	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—CHAT—amyotrophic lateral sclerosis	4.93e-05	0.000328	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	4.85e-05	0.000323	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	4.81e-05	0.00032	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—DAO—amyotrophic lateral sclerosis	4.64e-05	0.000309	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.52e-05	0.000301	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	4.47e-05	0.000298	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.37e-05	0.000291	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.15e-05	0.000277	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	3.99e-05	0.000266	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—VAPB—amyotrophic lateral sclerosis	3.95e-05	0.000263	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—TPK1—amyotrophic lateral sclerosis	3.95e-05	0.000263	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.84e-05	0.000256	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.84e-05	0.000256	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	3.7e-05	0.000247	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—VAPA—amyotrophic lateral sclerosis	3.61e-05	0.000241	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.53e-05	0.000235	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.53e-05	0.000235	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—PLB1—amyotrophic lateral sclerosis	3.51e-05	0.000234	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—APOE—amyotrophic lateral sclerosis	3.41e-05	0.000228	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—SACM1L—amyotrophic lateral sclerosis	3.36e-05	0.000224	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	3.33e-05	0.000222	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—GSR—amyotrophic lateral sclerosis	3.24e-05	0.000216	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—FIG4—amyotrophic lateral sclerosis	3.16e-05	0.00021	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	3.14e-05	0.000209	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.12e-05	0.000208	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—APOE—amyotrophic lateral sclerosis	2.9e-05	0.000193	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—APOE—amyotrophic lateral sclerosis	2.9e-05	0.000193	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.87e-05	0.000191	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.86e-05	0.000191	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—DAO—amyotrophic lateral sclerosis	2.86e-05	0.00019	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—CHAT—amyotrophic lateral sclerosis	2.66e-05	0.000177	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.65e-05	0.000176	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.63e-05	0.000175	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.43e-05	0.000162	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	2.37e-05	0.000158	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—APOE—amyotrophic lateral sclerosis	2.36e-05	0.000157	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.34e-05	0.000156	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—PLB1—amyotrophic lateral sclerosis	2.17e-05	0.000144	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—APOE—amyotrophic lateral sclerosis	2.16e-05	0.000144	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—APOE—amyotrophic lateral sclerosis	2e-05	0.000133	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—GSR—amyotrophic lateral sclerosis	2e-05	0.000133	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.99e-05	0.000133	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.99e-05	0.000133	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—CHAT—amyotrophic lateral sclerosis	1.64e-05	0.000109	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.62e-05	0.000108	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.48e-05	9.87e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.43e-05	9.54e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.37e-05	9.14e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.32e-05	8.76e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—APOE—amyotrophic lateral sclerosis	1.08e-05	7.21e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	8.82e-06	5.88e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	8.1e-06	5.4e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—PTGS2—amyotrophic lateral sclerosis	7.42e-06	4.94e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—APOE—amyotrophic lateral sclerosis	6.67e-06	4.44e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.57e-06	3.04e-05	CbGpPWpGaD
